

A practical guide for providers on helping patients locate Compro (Prochlorperazine) suppositories, including pharmacy sourcing strategies, alternatives, and workflow tips.
You've written a prescription for Compro (Prochlorperazine 25 mg suppositories) because your patient needs an antiemetic they can actually absorb — they're vomiting too severely for oral medications. Two days later, the patient calls back: "My pharmacy doesn't have it. No one has it."
This scenario has become frustratingly common. Compro suppositories, while clinically valuable, occupy a niche in the pharmaceutical supply chain that makes consistent availability a challenge. As a provider, you can play a meaningful role in helping patients navigate these gaps — and in preventing them from becoming treatment interruptions.
This guide gives you practical strategies for helping your patients locate Compro, knowing when to pivot to alternatives, and building availability awareness into your prescribing workflow.
As of 2026, Compro suppositories are not in a formal FDA-listed shortage, but availability at the pharmacy counter remains inconsistent. The core issues:
The oral tablets (5 mg and 10 mg) are generally available without significant difficulty. The supply challenge is specific to the suppository and injectable formulations.
When patients report they "can't find" Compro, they're typically encountering one of these barriers:
Before your patient starts calling pharmacies at random, direct them to Medfinder. This tool lets patients search for medication availability by name and location, identifying which pharmacies near them currently have Compro or generic prochlorperazine suppositories in stock.
This single step can save patients hours of phone calls and reduce the risk that they give up and go without their antiemetic.
When writing the prescription, include both the brand name (Compro) and the generic name (prochlorperazine 25 mg suppository). Also indicate on the prescription that generic substitution is permitted. This gives the pharmacist maximum flexibility to fill with whatever manufacturer's product is available.
When chain pharmacies come up empty, independent pharmacies are often the solution. They typically:
If you work with patients who frequently need suppository formulations, consider maintaining a short list of local independent pharmacies known for stocking or sourcing these products.
Compounding pharmacies can prepare prochlorperazine suppositories as a custom formulation when the commercial product is unavailable. This requires:
Compounded suppositories may cost more than commercial products, but they provide a reliable fallback when supply is disrupted.
For patients who depend on prochlorperazine suppositories, proactively document alternative antiemetic regimens in their chart. This way, if the patient calls in unable to find Compro, your team can quickly authorize a switch without requiring a full office visit. Useful alternatives to have ready:
When Compro isn't available and the clinical situation requires an alternative:
For a detailed comparison, see our Alternatives to Compro guide.
To minimize the impact of Compro availability issues on your patients and practice:
Compro availability is a supply chain problem, not a clinical one. The medication works. The challenge is getting it into your patient's hands. By directing patients to the right tools, building flexibility into your prescribing, and having documented alternatives ready, you can turn a supply chain headache into a manageable workflow step.
For the latest on Compro supply, see our provider shortage briefing. For patient-facing resources you can share, see How to Find Compro in Stock and How to Save Money on Compro.
You focus on staying healthy. We'll handle the rest.
Try Medfinder Concierge FreeMedfinder's mission is to ensure every patient gets access to the medications they need. We believe this begins with trustworthy information. Our core values guide everything we do, including the standards that shape the accuracy, transparency, and quality of our content. We’re committed to delivering information that’s evidence-based, regularly updated, and easy to understand. For more details on our editorial process, see here.